Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence โ Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022โ2025 | Base Year: 2025 | Forecast Period: 2026โ2034 |
|---|---|
| Form Outlook: Segment | Powdered Extract, Liquid Extract |
| Product Type Outlook: Segment | 25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid, Others |
| End Use Outlook: Segment | Food and Beverage, Nutraceuticals, Pharmaceuticals, Cosmetics |
|---|---|
| Regions & Countries |
|
Increasing Demand for Organic and Natural Products to boosts the need for advanced Ursolic Acid Rise in Chronic Illness to drive market growth Growing disposable incomes for market expansion
High expenditures related with ursodeoxycholic acid of Ursolic Acid limit market growth Increasing Variations in the quantity of raw materials available in Ursolic Acid designs can hinder market adoption
Raising awareness of liver diseases Increasing funding for studies to create alternative therapies in Ursolic Acid
Country-level data ยท Company profiles ยท Editable dataset ยท Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|
A = Actual ยท E = Estimated ยท P = Projected ยท ๐ Locked values require full access. Click headers to sort.
Unlock full regional dataset โCharts are illustrative โ exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The Ursolic Acid Market is highly competitive, characterized by the presence of several global and regional players offering a wide range of products. Key companies in the market, such as Vidya Europe SAS, Sabinsa Corporation, Kingherbs Limited, and BASF S.E., dominate through their extensive product portfolios, strong distribution networks, and focus on innovation.
In June 2024, Ipsen declared that Iqirvo (elafibranor) 80 mg tablets, which are used to treat primary biliary cholangitis (PBC) in adults, have received accelerated approval from the U.S. FDA. It can be used as monotherapy for people who cannot tolerate ursodeoxycholic acid (UDCA) or in conjunction with UDCA for people who do not respond well to UDCA. In the United States, Iqirvo is now accessible to qualified patients. https://www.empr.com/home/news/iqirvo-gets-accelerated-approval-for-primary-biliary-cholangitis/ In April 2022, The company's position in the active pharmaceutical ingredients market was greatly strengthened by the merger of PharmaZell, Farmabios, and Novasep to become Axplora. The market is anticipated to grow exponentially as a result of this combination. https://www.axplora.com/farmabios-novasep-and-pharmazell-are-now-axplora/
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Vidya Europe SAS | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Sabinsa Corporation | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Kingherbs Limited | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| BASF S.E. | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Santa Cruz Biotechnology | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Inc. | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Cayman Chemical Company | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Inc. | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Merck KGaA | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Wilshire Technologies | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Inc. | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| ALB Technology Limited | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Vitiva d.d. | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Biosearch Life | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Hainan Super Biotech Co. Ltd. | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| PharmaZell | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Ipsen | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Gilead Sciences | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
| Inc. | โขโขโข | โขโขโข | โขโขโข | โขโขโข |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation โAccording to Cognitive Market Research, the global Ursolic Acid Market size will be USD 2148 million in 2025. It will expand at a compound annual growth rate (CAGR) of 7.60%from 2025 to 2033.
Numerous fruits, vegetables, and therapeutic herbs naturally contain ursolic acid, a pentacyclic triterpenoid molecule. Its many pharmacological qualities, such as anti-inflammatory, antioxidant, antibacterial, and anti-cancer activities, have earned it widespread recognition. Ursolic acid's structural lipophilia helps explain its capacity to interact with cellular membranes and alter biological processes. It is frequently employed in the medical field as a therapeutic agent to treat chronic illnesses and enhance general health. Ursolic acid is prized in cosmetics for its capacity to improve skin elasticity, lessen wrinkles, and shield the skin from UV ray damage.It is also included in dietary supplements to promote metabolic health, weight loss, and muscle growth.Due to its effectiveness and adaptability, the chemical is in high demand worldwide as an ingredient in a variety of sectors.
In August 2024, The U.S. FDA has given Livdelzi (seladelpar) expedited approval to treat adult primary biliary cholangitis (PBC), according to a statement released by Gilead Sciences, Inc. It can be used as monotherapy for patients who cannot tolerate ursodeoxycholic acid (UDCA) or in combination with UDCA for those who do not respond well to it. Patients with decompensated cirrhosis should not use Livdelzi. https://www.gilead.com/news/news-details/2024/gileads-livdelzi-seladelpar-granted-accelerated-approval-for-primary-biliary-cholangitis-by-us-fda
Conclusion
★ Reviews
Rate this report
| Form Outlook: | Powdered Extract, Liquid Extract |
| Product Type Outlook: | 25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid, Others |
| End Use Outlook: | Food and Beverage, Nutraceuticals, Pharmaceuticals, Cosmetics |
| List of Competitors | Vidya Europe SAS, Sabinsa Corporation, Kingherbs Limited, BASF S.E., Santa Cruz Biotechnology, Inc., Cayman Chemical Company, Inc., Merck KGaA, Wilshire Technologies, Inc., ALB Technology Limited, Vitiva d.d., Biosearch Life, Hainan Super Biotech Co. Ltd., PharmaZell, Ipsen, Gilead Sciences, Inc. |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truthโข" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Ursolic Acid Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Ursolic Acid Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the ursolic acid market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need โ and we will tailor the deliverable to your requirements.